Cas 503145-83-3,3-[(S)-6-acetoxy-2-(benzyloxycarbonyl)aminohexanoyl]-1,3-thiazolidine

503145-83-3

Post Buying Request

Basic information

Product Name: 3-[(S)-6-acetoxy-2-(benzyloxycarbonyl)aminohexanoyl]-1,3-thiazolidine
Synonyms: 3-[(S)-6-acetoxy-2-(benzyloxycarbonyl)aminohexanoyl]-1,3-thiazolidine
CAS NO:503145-83-3
Molecular Formula:
Molecular Weight: 394.492
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-[(S)-6-acetoxy-2-(benzyloxycarbonyl)aminohexanoyl]-1,3-thiazolidine(CAS DataBase Reference)
NIST Chemistry Reference: 3-[(S)-6-acetoxy-2-(benzyloxycarbonyl)aminohexanoyl]-1,3-thiazolidine(503145-83-3)
EPA Substance Registry System: 3-[(S)-6-acetoxy-2-(benzyloxycarbonyl)aminohexanoyl]-1,3-thiazolidine(503145-83-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 503145-83-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

503145-83-3 Suppliers

Recommended suppliers

503145-83-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 503145-83-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,3,1,4 and 5 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 503145-83:
(8*5)+(7*0)+(6*3)+(5*1)+(4*4)+(3*5)+(2*8)+(1*3)=113
113 % 10 = 3
So 503145-83-3 is a valid CAS Registry Number.

503145-83-3Upstream product

503145-83-3Downstream Products

503145-87-7 3-[(S)-2-(benzyloxycarbonyl)amino-6-hydroxyhexanoyl)-1,3-thiazolidine

503145-83-3Relevant academic research and scientific papers

THIAZOLIDINE DERIVATIVE AND MEDICINAL USE THEREOF

-

Page 28-29, (2010/02/07)

A thiazolidine derivative represented by the formula (I) wherein each symbol is as defined in the specification, and a pharmaceutically acceptable salt thereof exhibit a potent DPP-IV inhibitory activity, and can be provided as an agent for the prophylaxis or treatment of diabetes, an agent for the prophylaxis or treatment of obesity and the like.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 503145-83-3